NO123427B - - Google Patents
Download PDFInfo
- Publication number
- NO123427B NO123427B NO16631467A NO16631467A NO123427B NO 123427 B NO123427 B NO 123427B NO 16631467 A NO16631467 A NO 16631467A NO 16631467 A NO16631467 A NO 16631467A NO 123427 B NO123427 B NO 123427B
- Authority
- NO
- Norway
- Prior art keywords
- phenylcyclohexylamine
- trans
- acid
- salts
- biphenylyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 claims description 20
- SJISCEAZUHNOMD-UHFFFAOYSA-N 4-phenylcyclohexan-1-amine Chemical class C1CC(N)CCC1C1=CC=CC=C1 SJISCEAZUHNOMD-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000000114 Pain Threshold Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000037040 pain threshold Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- JALUUBQFLPUJMY-UHFFFAOYSA-N 2-(4-phenylphenyl)propanoic acid Chemical class C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 JALUUBQFLPUJMY-UHFFFAOYSA-N 0.000 description 3
- -1 4-biphenylyl Chemical group 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- IYEPZNKOJZOGJG-UHFFFAOYSA-N xenbucin Chemical class C1=CC(C(C(O)=O)CC)=CC=C1C1=CC=CC=C1 IYEPZNKOJZOGJG-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001760 anti-analgesic effect Effects 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- JTLAHVRPWDIEMU-UHFFFAOYSA-N n-(4-phenylcyclohexylidene)hydroxylamine Chemical compound C1CC(=NO)CCC1C1=CC=CC=C1 JTLAHVRPWDIEMU-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LGJWPXGDZJETQK-UHFFFAOYSA-N 4-(2-phenylphenyl)butanoic acid Chemical compound OC(=O)CCCC1=CC=CC=C1C1=CC=CC=C1 LGJWPXGDZJETQK-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- SJISCEAZUHNOMD-HAQNSBGRSA-N C1C[C@@H](N)CC[C@@H]1C1=CC=CC=C1 Chemical class C1C[C@@H](N)CC[C@@H]1C1=CC=CC=C1 SJISCEAZUHNOMD-HAQNSBGRSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 150000003946 cyclohexylamines Chemical class 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- TXTHKGMZDDTZFD-UHFFFAOYSA-N n-cyclohexylaniline Chemical class C1CCCCC1NC1=CC=CC=C1 TXTHKGMZDDTZFD-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1339866 | 1966-01-14 | ||
| IT1952966 | 1966-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO123427B true NO123427B (cs) | 1971-11-15 |
Family
ID=26326642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO16631467A NO123427B (cs) | 1966-01-14 | 1967-01-09 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE692583A (cs) |
| DE (1) | DE1618632B1 (cs) |
| DK (1) | DK126107B (cs) |
| ES (1) | ES335177A1 (cs) |
| GR (1) | GR33295B (cs) |
| NO (1) | NO123427B (cs) |
| SE (1) | SE324764B (cs) |
-
1966
- 1966-12-30 DK DK677866A patent/DK126107B/da unknown
-
1967
- 1967-01-02 ES ES0335177A patent/ES335177A1/es not_active Expired
- 1967-01-09 NO NO16631467A patent/NO123427B/no unknown
- 1967-01-10 GR GR670133295A patent/GR33295B/el unknown
- 1967-01-11 SE SE40867A patent/SE324764B/xx unknown
- 1967-01-11 DE DE1967M0072375 patent/DE1618632B1/de active Pending
- 1967-01-13 BE BE692583D patent/BE692583A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE692583A (cs) | 1967-06-16 |
| ES335177A1 (es) | 1967-11-16 |
| GR33295B (el) | 1967-11-21 |
| DK126107B (da) | 1973-06-12 |
| DE1618632B1 (de) | 1971-11-11 |
| SE324764B (cs) | 1970-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3067101A (en) | Method for controlling hypertension | |
| Freudenberg et al. | Study on the Configuration of EPHEDRINE1 | |
| DE2202728A1 (de) | Substituierte Indensaeuren | |
| DE2463219C2 (cs) | ||
| DE69414194T2 (de) | Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren | |
| EP0005559B1 (de) | Phenylaminothiophenessigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE2044172C3 (de) | Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE2511647A1 (de) | Neue benzopyranderivate | |
| NO123427B (cs) | ||
| EP0012801B1 (de) | 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel | |
| DE2202715A1 (de) | Substituierte Indenylessigsaeuren | |
| US3153050A (en) | Spiro | |
| BURGER et al. | 2-Phenylcyclobutanecarboxylic Acid1 | |
| DE2039426B2 (cs) | ||
| DE1618817C3 (de) | 17-Äther von 4,9,11-Gona-trienen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Formulierungen | |
| US3719713A (en) | Fluorinated beta-phenyl-alpha-methylethylamines | |
| Sunko et al. | Studies in the Sphingolipids Series. II. Synthesis of Enantiomeric Sphingines | |
| EP0019739B1 (de) | 2-Aminoalkyl-5-pyridinole, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten | |
| NO137893B (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner | |
| DE2804837C2 (de) | Arzneimittel auf der Basis von Cysteinol- und Homocysteinol-Derivaten | |
| DE2263817A1 (de) | Organische verbindungen | |
| NO121344B (cs) | ||
| DE2234706A1 (de) | Derivate von 9-oxo-13-trans-prostensaeureestern | |
| US3799982A (en) | N-(beta,beta-difluoro,alpha-methylphenethyl)-formamide | |
| DE2337120A1 (de) | 4,5,6 oder 7-indenylsaeuren |